CIK 0001840706
- Accelerated filer
- Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Other
- Phone
- +41 216941060
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- 4 Planned sale Chief Scientific Officer sold 4,000 shares at $7.88 ($31,538)
- 4 Planned sale Chief Legal Officer sold 6,168 shares at $7.63 ($47,089)
- 4 Planned sale Executive Chairman sold 8,500 shares at $7.66 ($65,120)
- 4 Planned sale Director sold 6,250 shares at $8.13 ($50,818)
- 4 Planned sale Chief Scientific Officer sold 10,000 shares at $8.91 ($89,096)
- 4 Planned sale Chief Medical Officer sold 5,000 shares at $8.68 ($43,397)
- 4 Planned sale Director sold 6,250 shares at $8.68 ($54,233)
- 4 Planned sale Chief Technology Officer sold 10,000 shares at an average $8.50 ($85,000)
- 4 Planned sale Chief People Officer sold 10,000 shares at $7.94 ($79,439)
- 4 Planned sale Chief Scientific Officer sold 20,000 shares at an average $8.17 ($163,482)
- 4 Planned sale Chief Medical Officer sold 5,000 shares at $7.52 ($37,580)
- 4 Planned sale Chief Scientific Officer sold 4,000 shares at $7.52 ($30,076)
- 4 Planned sale Chief Technology Officer sold 5,000 shares at $7.60 ($38,000)
- 4 Planned sale Executive Chairman sold 28,500 shares at an average $7.34 ($209,209)
- 4 Planned sale Chief Scientific Officer sold 20,000 shares at an average $7.25 ($144,924)
- 4 Planned sale Chief Technology Officer sold 5,000 shares at $6.95 ($34,772)
- 4 Planned sale Executive Chairman sold 20,000 shares at $6.92 ($138,412)
- 4 Planned sale Chief Scientific Officer sold 10,000 shares at $6.92 ($69,168)
- 4 Planned sale Chief Medical Officer sold 5,000 shares at $5.66 ($28,306)
- 4 Planned sale Executive Chairman sold 44,381 shares at an average $6.45 ($286,099)
Page 2 of 8 · 154 filings